ID: ALA379891

Max Phase: Preclinical

Molecular Formula: C20H14ClNO3S

Molecular Weight: 383.86

Molecule Type: Small molecule

Representations

Canonical SMILES:  Cc1c(Cl)sc2nc(O)c(-c3cccc(Oc4ccccc4)c3)c(O)c12

Standard InChI:  InChI=1S/C20H14ClNO3S/c1-11-15-17(23)16(19(24)22-20(15)26-18(11)21)12-6-5-9-14(10-12)25-13-7-3-2-4-8-13/h2-10H,1H3,(H2,22,23,24)

Standard InChI Key:  WHNRNSBFFQOJPP-UHFFFAOYSA-N

Molecule Features

Natural Product: No

Oral: No

Chemical Probe: No

Parenteral: No

Molecule Type: Small molecule

Topical: No

First In Class: No

Black Box: No

Chirality: No

Availability: No

Prodrug: No

Properties

Molecular Weight: 383.86

Molecular Weight (Monoisotopic): 383.0383

AlogP: 6.13

#Rotatable Bonds: 3

Polar Surface Area: 62.58

Molecular Species: NEUTRAL

HBA: 5

HBD: 2

#RO5 Violations: 1

HBA (Lipinski): 4

HBD (Lipinski): 2

#RO5 Violations (Lipinski): 1

CX Acidic pKa: 9.39

CX Basic pKa:

CX LogP: 6.42

CX LogD: 6.41

Aromatic Rings: 4

Heavy Atoms: 26

QED Weighted: 0.45

Np Likeness Score: -0.46

References

1. Buchstaller HP, Siebert CD, Steinmetz R, Frank I, Berger ML, Gottschlich R, Leibrock J, Krug M, Steinhilber D, Noe CR..  (2006)  Synthesis of thieno[2,3-b]pyridinones acting as cytoprotectants and as inhibitors of [3H]glycine binding to the N-methyl-D-aspartate (NMDA) receptor.,  49  (3): [PMID:16451052] [10.1021/jm0503493]

Source

Source(1):

• Scientific Literature